Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.

Ryo KurashinaToshiki KijimaAkihito OkazakiHirotaka FuchizawaIssei SuzukiKazumasa SakamotoHironori BetsunohYoshitatsu FukaboriMasahiro YashiTakao Kamai

Published in: IJU case reports (2020)

Our case suggests that whole-body diffusion-weighted magnetic resonance imaging is useful in disease management for treatment-related neuroendocrine prostate cancer as well as the potential evaluation of mixed responses and treatment resistance.

Keyphrases

prostate cancer
diffusion weighted
magnetic resonance imaging
contrast enhanced
radical prostatectomy
computed tomography
combination therapy
replacement therapy